KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Common Equity: 2013-2025

Historic Common Equity for CareDx (CDNA) over the last 12 years, with Sep 2025 value amounting to $311.1 million.

  • CareDx's Common Equity rose 13.87% to $311.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $311.1 million, marking a year-over-year increase of 13.87%. This contributed to the annual value of $378.4 million for FY2024, which is 44.81% up from last year.
  • Latest data reveals that CareDx reported Common Equity of $311.1 million as of Q3 2025, which was down 4.96% from $327.4 million recorded in Q2 2025.
  • CareDx's 5-year Common Equity high stood at $479.8 million for Q2 2021, and its period low was $256.2 million during Q1 2024.
  • Its 3-year average for Common Equity is $333.7 million, with a median of $327.4 million in 2025.
  • Its Common Equity has fluctuated over the past 5 years, first spiked by 365.11% in 2021, then plummeted by 39.35% in 2023.
  • CareDx's Common Equity (Quarterly) stood at $465.9 million in 2021, then declined by 7.51% to $430.9 million in 2022, then plummeted by 39.35% to $261.3 million in 2023, then spiked by 44.81% to $378.4 million in 2024, then increased by 13.87% to $311.1 million in 2025.
  • Its Common Equity stands at $311.1 million for Q3 2025, versus $327.4 million for Q2 2025 and $379.3 million for Q1 2025.